Clear Search

Showing 1 result for “Penso L”.

May 2022

乾癬性関節炎で生物学的製剤またはアプレミラストを 開始した患者の主要心血管イベントシルク: ナショナル レジストリ

doi: 10.1093/rheumatology/keab522

Pina Vegas and her colleagues sought to assess the relative risk of MACEs in patients with PsA initiating bDMARDs or apremilast. They found that overall, the data produced overall a positive picture regarding the incidence of MACE in treatment.